Uk.Investing Cellebrite Reports Strong Q1 2026 Results Amid AI Product Launches
Article Content
- •Cellebrite's Q1 2026 ARR grew 21% year-over-year to $493 million.
- •The launch of AI platforms Genesis and Guardian Investigate is expected to drive future revenue growth.
- •Cellebrite secured FedRAMP High Authorization, enhancing its federal sales opportunities.
Cellebrite DI Ltd. announced its financial results for Q1 2026, highlighting a 21% year-over-year growth in annual recurring revenue (ARR) to $493 million. The company launched two AI-driven platforms, Genesis and Guardian Investigate, in March 2026, which are designed to enhance digital investigations. Total revenue for the quarter reached $128.3 million, a 19% increase, with a significant shift towards higher-margin software subscriptions. Despite a seasonal decline in training and hardware services, executives expressed optimism about future growth, particularly in the federal sector following their recent FedRAMP High Authorization. The company expects to capture a substantial share of the estimated $12.5 billion market for investigative AI over the next four years. Adjusted EBITDA rose 29% to $30.6 million, indicating improved operating leverage. The stock remains a strong buy among analysts, with a target price suggesting significant upside potential.
Ask AI about this cluster
Answers cite the sources they use
Timeline
More articles in this cluster (4)
Following this threat?
Track Genesis in your own feed — you're alerted when they show up in new reporting, leak sites or exploitation.
Free account · no card needed